Table of Contents

Virology is the branch of biology that studies viruses — submicroscopic infectious agents that replicate only inside the living cells of other organisms. Virologists investigate how viruses are structured, how they infect and replicate within host cells, how they cause disease, and how they can be prevented or treated.

Viruses infect every form of life on Earth, from bacteria to blue whales, and they outnumber every other biological entity on the planet by orders of magnitude.

What Exactly Is a Virus?

This seems like it should be a simple question. It isn’t.

A virus is, at its most basic, a piece of genetic material (DNA or RNA) wrapped in a protein shell. That’s it. No nucleus. No mitochondria. No ribosomes. No metabolism. A virus sitting on a tabletop is essentially an inert particle — a complicated chemical. But introduce it to the right host cell, and it springs into action, hijacking the cell’s machinery to make copies of itself.

This is the fundamental paradox of viruses. Outside a cell, they do absolutely nothing. Inside a cell, they can bring down an entire organism.

The typical virus is staggeringly small. Most range from 20 to 300 nanometers in diameter. For perspective: if a bacterium were the size of a football field, a typical virus would be the size of a person standing in it. You need an electron microscope to see most viruses — light microscopes don’t have the resolution.

Virus Structure

Despite their simplicity, viruses have elegant architecture. The basic components:

Genetic material — either DNA or RNA, never both. This can be single-stranded or double-stranded, linear or circular. The genome size varies enormously: some viruses have fewer than 2,000 nucleotides (barely enough to encode a couple of proteins), while the giant Mimivirus genome contains over 1.2 million base pairs — larger than some bacteria.

Capsid — the protein shell protecting the genetic material. Capsids self-assemble from repeating protein subunits (capsomeres) into geometric shapes, most commonly icosahedral (20-faced, soccer ball-like) or helical (rod-shaped). The geometry is dictated by physics and energy minimization — these shapes use the minimum amount of protein to enclose the maximum volume.

Envelope — some viruses (like influenza, HIV, and SARS-CoV-2) have an outer lipid membrane stolen from the host cell during exit. This envelope is studded with viral proteins (like the famous spike protein of SARS-CoV-2) that help the virus attach to and enter new cells. Enveloped viruses are generally easier to kill with soap and disinfectants because disrupting the lipid layer inactivates them.

Other components — some viruses carry enzymes inside their particles. HIV carries reverse transcriptase (to convert its RNA genome into DNA). Influenza carries neuraminidase (to help newly made viruses escape the host cell). These enzymes are often targets for antiviral drugs.

How Viruses Replicate

Viruses can’t reproduce on their own — they need to commandeer a host cell’s machinery. The replication cycle, while it varies among virus families, follows a general pattern.

Attachment. The virus binds to specific receptor proteins on the host cell surface. This interaction is highly specific — like a key fitting a lock. HIV binds to the CD4 receptor on T-helper cells. SARS-CoV-2 binds to the ACE2 receptor on respiratory epithelial cells. This receptor specificity determines which species and which cell types a virus can infect (called tropism).

Entry. The virus or its genetic material gets inside the cell. Enveloped viruses often fuse their membrane with the cell membrane. Non-enveloped viruses may be engulfed by endocytosis or inject their genome through the cell wall (as bacteriophages do).

Uncoating. The capsid disassembles, releasing the viral genome into the cell.

Replication and gene expression. This is where it gets complicated, because different viruses use different strategies. DNA viruses typically use the host cell’s enzymes to copy their DNA and transcribe it into messenger RNA. RNA viruses need their own RNA-dependent RNA polymerase (an enzyme that copies RNA from an RNA template) because host cells don’t have one. Retroviruses like HIV reverse-transcribe their RNA genome into DNA, which then integrates into the host chromosome — a strategy that seemed so bizarre when first discovered that it challenged the “central dogma” of molecular biology.

Assembly. New viral proteins and genome copies come together to form new virus particles. This often happens at specific locations in the cell — the nucleus, the cytoplasm, or the cell membrane.

Release. New viruses exit the cell. Some burst out, destroying the cell in the process (lysis). Others bud out through the cell membrane, acquiring their envelope in the process and leaving the cell intact (for now). The release mechanism determines how much immediate damage the virus causes to the infected tissue.

A single infected cell can produce hundreds or thousands of new virus particles. Multiply that across millions of infected cells, and you begin to understand how viral infections can overwhelm the body so quickly.

The Baltimore Classification System

David Baltimore (who won the Nobel Prize in 1975) devised an elegant system for classifying viruses based on how they produce messenger RNA — because regardless of genome type, every virus needs mRNA to make proteins using the host cell’s ribosomes.

The seven Baltimore classes:

• Class I: Double-stranded DNA (dsDNA) — herpesviruses, adenoviruses, poxviruses
• Class II: Single-stranded DNA (ssDNA) — parvoviruses
• Class III: Double-stranded RNA (dsRNA) — reoviruses, rotaviruses
• Class IV: Positive-sense single-stranded RNA (+ssRNA) — coronaviruses, flaviviruses, picornaviruses
• Class V: Negative-sense single-stranded RNA (-ssRNA) — influenza, Ebola, rabies
• Class VI: Retroviruses (ssRNA with reverse transcription) — HIV
• Class VII: Pararetroviruses (dsDNA with reverse transcription) — hepatitis B

The classification matters practically because the replication strategy determines which antiviral approaches will work. Drugs that inhibit reverse transcriptase work against retroviruses but are useless against DNA viruses. Understanding the Baltimore class immediately tells you something about how to fight the virus.

Viruses That Changed History

The impact of viruses on human civilization is hard to overstate.

Smallpox killed an estimated 300-500 million people in the 20th century alone, and far more throughout history. It decimated indigenous populations in the Americas after European contact. Its eradication through vaccination in 1980 remains one of humanity’s greatest achievements — and a triumph of virology.

The 1918 influenza pandemic killed 50-100 million people worldwide — more than World War I. The virus was an H1N1 strain of avian origin. It took until 2005 to reconstruct the 1918 virus from preserved tissue samples, finally explaining its unusual severity.

HIV/AIDS has killed over 40 million people since the epidemic began in the early 1980s. The development of antiretroviral therapy — which emerged from understanding HIV’s replication cycle in molecular detail — transformed AIDS from a death sentence into a manageable chronic condition for those with access to treatment.

COVID-19 caused by SARS-CoV-2, killed millions worldwide and reshaped global society. The pandemic also demonstrated the effect of modern virology — the virus was sequenced within weeks of its identification, and effective vaccines were developed in under a year using mRNA technology.

Polio paralyzed hundreds of thousands of children annually before the Salk and Sabin vaccines. Global eradication efforts have reduced cases by 99.9%, from 350,000 cases in 1988 to fewer than 100 wild poliovirus cases annually in recent years.

Vaccines: Virology’s Greatest Triumph

Vaccines are the most impactful application of virology, preventing billions of infections and saving millions of lives every year.

The principle is straightforward: expose the immune system to a harmless version of the virus (or a piece of it) so it builds immunity before encountering the real thing. The implementation varies:

Live attenuated vaccines use weakened versions of the virus that can replicate but don’t cause serious disease. Examples: MMR (measles, mumps, rubella), oral polio vaccine, yellow fever. They produce strong, long-lasting immunity but can’t be given to immunocompromised individuals.

Inactivated vaccines use killed virus particles. Examples: flu shot, injectable polio vaccine, hepatitis A. Safer for immunocompromised patients but generally produce weaker immunity requiring booster doses.

Subunit vaccines use specific viral proteins rather than whole virus particles. Examples: hepatitis B vaccine (uses just the surface antigen), HPV vaccine (uses virus-like particles made from capsid proteins). Very safe but may need adjuvants to boost the immune response.

mRNA vaccines — the newest approach — deliver genetic instructions for making a viral protein. Your cells temporarily produce the protein, the immune system responds, and the mRNA degrades within days. The Pfizer-BioNTech and Moderna COVID-19 vaccines proved this technology works at scale, and mRNA vaccines for influenza, RSV, and other viruses are in development.

Viral vector vaccines use a harmless virus (often an adenovirus) to deliver genes encoding the target virus’s proteins. The Oxford-AstraZeneca and Johnson & Johnson COVID-19 vaccines used this approach.

Antiviral Drugs: Fighting Active Infections

Unlike antibiotics — which exploit fundamental differences between bacterial and human cell biology — antiviral drugs face a harder problem. Viruses use the host cell’s own machinery, so drugs that kill the virus risk harming the cell.

Despite this challenge, virologists have developed effective antivirals by targeting virus-specific processes:

Entry inhibitors block the virus from entering cells. Maraviroc blocks HIV’s co-receptor, preventing entry.

Polymerase inhibitors block viral genome copying. Remdesivir (used against COVID-19) and acyclovir (used against herpesviruses) work this way.

Protease inhibitors block the enzymes that process viral proteins into functional forms. These were a game-changer for HIV treatment in the 1990s.

Neuraminidase inhibitors like oseltamivir (Tamiflu) block influenza virus release from infected cells.

Integrase inhibitors prevent HIV’s DNA from integrating into the host chromosome.

The combination approach — using multiple drugs targeting different steps simultaneously — is key to treating HIV. Monotherapy rapidly leads to drug resistance because viral populations are large and mutations are frequent. Combination therapy (HAART — Highly Active Antiretroviral Therapy) attacks the virus at multiple points, making resistance much less likely.

Viral Evolution and Emergence

Viruses evolve fast. Really fast. RNA viruses in particular mutate at rates roughly a million times higher than human DNA because RNA polymerases lack the error-correction mechanisms that DNA polymerases have. HIV accumulates mutations so rapidly that the viral population within a single patient after a few years is more genetically diverse than all influenza viruses worldwide in a given year.

This extreme mutation rate drives several important phenomena:

Antigenic drift — gradual accumulation of mutations in surface proteins that allow the virus to partially escape existing immunity. This is why you need a new flu shot every year — the influenza virus changes enough that last year’s antibodies don’t recognize this year’s strain well.

Antigenic shift — sudden, dramatic changes when different viral strains exchange genetic segments (reassortment). This can create entirely novel viruses against which nobody has immunity. Pandemic influenza strains typically emerge through antigenic shift.

Zoonotic spillover — viruses that normally infect animals acquiring the ability to infect humans through mutations. SARS-CoV-2, HIV, Ebola, and many influenza strains originated this way. The conditions promoting spillover include deforestation, wildlife trade, agriculture intensification, and increased human-wildlife contact.

Drug resistance — mutations that reduce the effectiveness of antiviral drugs. This is why monotherapy fails for HIV and why combination therapy is essential.

Modern Virology: Tools and Techniques

Contemporary virologists have an extraordinary toolkit.

Next-generation sequencing can determine a virus’s complete genetic sequence in hours. During the COVID-19 pandemic, genomic surveillance tracked the emergence and spread of variants in near-real-time, informing public health responses worldwide.

Reverse genetics allows virologists to create viruses from synthetic DNA, manipulate individual genes, and study how specific mutations affect viral properties. This technology was essential for creating the live attenuated influenza vaccine.

Cryo-electron microscopy (cryo-EM) can visualize virus structures at near-atomic resolution without crystallization. The structure of the SARS-CoV-2 spike protein — solved by cryo-EM within weeks of the virus’s emergence — guided vaccine and drug development.

Metagenomics surveys all genetic material in an environmental sample, revealing viruses that can’t be grown in the lab. This has revealed that the vast majority of viral diversity on Earth remains undiscovered. The ocean alone contains an estimated 10^31 virus particles — more than the number of stars in the observable universe.

Organoids and organ-on-a-chip systems model human organs in miniature, allowing virologists to study viral infections in more realistic contexts than traditional cell cultures without requiring animal testing.

Bacteriophages: Viruses as Tools

Not all viruses are enemies. Bacteriophages — viruses that infect bacteria — are being explored as alternatives to antibiotics with rising antimicrobial resistance.

Phage therapy, first attempted in the early 1900s, fell out of favor in the West when antibiotics arrived. But it continued in the Soviet Union and Georgia, where phage therapy centers treated bacterial infections for decades. Now, with antibiotic-resistant superbugs threatening modern medicine, Western researchers are revisiting phages.

The advantage of phages: they’re highly specific, killing only the target bacterial species and leaving beneficial bacteria unharmed (unlike broad-spectrum antibiotics). The challenge: their specificity means you need to match the right phage to the right bacterium, and bacteria can evolve resistance to phages just as they do to antibiotics.

Several case reports and small clinical trials have shown phage therapy saving patients with antibiotic-resistant infections that were otherwise untreatable. The FDA has approved compassionate use of phage therapy in individual cases, and formal clinical trials are underway.

What We Still Don’t Know

For all its advances, virology remains a field with enormous gaps.

We’ve identified only a tiny fraction of Earth’s viruses. An estimated 1.67 million undiscovered viral species exist in mammalian and bird hosts, of which 631,000-827,000 are estimated to have the potential to infect humans. We’re essentially waiting for the next pandemic pathogen to announce itself.

We still can’t cure most viral infections. We manage HIV but don’t eradicate it. We treat hepatitis C (a genuine cure, and a remarkable achievement), but most viral infections have no specific treatment — your immune system either handles it or it doesn’t.

The origin of viruses remains debated. Did they predate cellular life? Did they evolve from escaped cellular genetics? Did they emerge from degenerate cells that lost everything except their genomes? All three hypotheses have evidence; none is conclusive.

Virology is a field where the stakes are literally existential. The next pandemic virus is already out there, circulating in some animal population, accumulating mutations that might — or might not — allow it to jump to humans. Understanding viruses isn’t just academic curiosity. It’s survival preparation.

Frequently Asked Questions

Are viruses alive?

This is one of biology's most debated questions. Viruses can't reproduce on their own, don't metabolize, and aren't made of cells — all features typically associated with life. But they evolve, have genetic material, and interact with biological systems. Most biologists consider them 'organisms at the edge of life' rather than fully living or nonliving.

How are viruses different from bacteria?

Viruses are much smaller (typically 20-300 nanometers vs. 1-10 micrometers for bacteria), lack cellular structure, can't reproduce independently, and contain either DNA or RNA but not both. Bacteria are complete cells that can reproduce on their own. Antibiotics kill bacteria but don't work against viruses.

Can viruses be beneficial?

Yes. Bacteriophages (viruses that infect bacteria) are being explored as alternatives to antibiotics. Some viruses are used in gene therapy to deliver corrective genes to patients. Certain viral infections may even prime the immune system in ways that reduce risk of allergies or autoimmune diseases.

How do new viruses emerge?

Most new human viruses come from animals (zoonotic spillover) when mutations allow an animal virus to infect human cells. Factors like deforestation, wildlife trade, intensive farming, and urbanization increase contact between humans and animal reservoirs, creating more opportunities for spillover.

Why can't we cure the common cold?

The 'common cold' is caused by over 200 different viruses across multiple families. Rhinoviruses alone have more than 100 types. Developing a single vaccine or drug that works against all of them is extremely difficult, and the infections are mild enough that the research investment hasn't been prioritized.

Further Reading

• CDC - Viral Diseases
• NIH - National Institute of Allergy and Infectious Diseases
• WHO - Diseases and Conditions
• American Society for Virology